Literature DB >> 15941375

Progesterone differentially regulates pro- and anti-apoptotic gene expression in cerebral cortex following traumatic brain injury in rats.

Xiang-Lan Yao1, Jiong Liu, Eleanor Lee, Geoffrey S F Ling, Joseph T McCabe.   

Abstract

Although the administration of progesterone has been shown to be neuroprotective in experimental models of traumatic brain injury (TBI), the mechanisms for this beneficial effect are still poorly understood. The present study examined the effects of progesterone on mRNA and protein levels of the Bcl-2 apoptosis regulatory genes, bax, bad, bcl-2, and bcl-x(L), in cerebral cortex after TBI. Male Sprague-Dawley rats were subjected to either sham surgery or lateral fluid percussion brain injury of moderate severity (2.4-2.6 atm). Within 1 h post-surgery, progesterone (4 mg/kg) or vehicle (corn oil) administration was initiated for 1-7 days postoperatively. Our results indicate that bax and bad mRNA levels and Bax and Bad protein expression in the ipsilateral, injured cerebral cortex were significantly elevated post-TBI, while mRNA levels of bcl-2 and bcl-x(L) or Bcl-2 and Bcl-x(L) protein expression were not changed. Under the sham-treated condition, progesterone significantly increased mRNA levels of the anti-apoptotic gene, bcl-2, but down-regulated pro-apoptotic gene expression (bax and bad) in cerebral cortex. After TBI, progesterone treatment reduced bax and bad mRNA levels in the ipsilateral cerebral cortex of TBI rats, and decreased Bax and Bad protein levels. In addition, bcl-2 and bcl-x(L) mRNA levels, as well as Bcl-2 and Bcl-x(L) protein expression, were increased by progesterone in TBI injured cortex. These data indicate that one of the neuroprotective mechanisms of progesterone may be related to its differential regulation of apoptotic signals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941375     DOI: 10.1089/neu.2005.22.656

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  29 in total

Review 1.  Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies.

Authors:  David J Loane; Alan I Faden
Journal:  Trends Pharmacol Sci       Date:  2010-10-29       Impact factor: 14.819

Review 2.  Progesterone exerts neuroprotective effects after brain injury.

Authors:  Donald G Stein
Journal:  Brain Res Rev       Date:  2007-07-27

3.  The effect of progesterone dose on gene expression after traumatic brain injury.

Authors:  Gail D Anderson; Federico M Farin; Theo K Bammler; Richard P Beyer; Alicia A Swan; Hui-Wen Wilkerson; Eric D Kantor; Michael R Hoane
Journal:  J Neurotrauma       Date:  2011-09-08       Impact factor: 5.269

Review 4.  Progesterone for neuroprotection in pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Emin Fidan; Rachel M Stanley; Corina Noje; Hülya Bayir
Journal:  Pediatr Crit Care Med       Date:  2015-03       Impact factor: 3.624

5.  Progesterone protects mitochondrial function in a rat model of pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Manda Saraswati
Journal:  J Bioenerg Biomembr       Date:  2014-10-28       Impact factor: 2.945

Review 6.  Sex differences in pediatric traumatic brain injury.

Authors:  Sheryl E Arambula; Erin L Reinl; Nagat El Demerdash; Margaret M McCarthy; Courtney L Robertson
Journal:  Exp Neurol       Date:  2019-03-02       Impact factor: 5.330

7.  Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF/TrkB/Erk1/2 signaling in neuroprotection.

Authors:  Fahim Atif; Seema Yousuf; Iqbal Sayeed; Tauheed Ishrat; Fang Hua; Donald G Stein
Journal:  Neuropharmacology       Date:  2012-11-12       Impact factor: 5.250

Review 8.  Sex, sex steroids, and brain injury.

Authors:  Paco S Herson; Ines P Koerner; Patricia D Hurn
Journal:  Semin Reprod Med       Date:  2009-04-28       Impact factor: 1.303

Review 9.  Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

Authors:  Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer
Journal:  J Neurotrauma       Date:  2014-01-15       Impact factor: 5.269

Review 10.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease.

Authors:  Milos Cekic; Iqbal Sayeed; Donald G Stein
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.